Posts about "healthcare"

Researchers at MIT and Harvard have developed CAR-NK cells—a type of immune cell engineered to be 'invisible' to the body's natural defenses—that can effectively target and destroy cancer cells without provoking dangerous immune reactions, showing potential as a major breakthrough in cancer treatment.

Paris-based Phagos, a biotech startup founded four years ago, raised €25 million in a Series A funding round to advance its innovative solutions in combating bacterial diseases. The funding was spearheaded by notable investors such as CapAgro and Hoxton Ventures, emphasizing the significance of developing alternative treatments in the face of rising antibiotic resistance.

Scientists have achieved a major breakthrough by directly imaging and measuring protein clusters in the human brain believed to trigger Parkinson’s disease, a discovery that marks a significant step in understanding and potentially treating the disorder.

Recent research reveals that bacteria residing inside tumors could become a powerful tool in combating cancer. These bacteria produce 2-methylisocitrate, a molecule that enhances the effectiveness of chemotherapy by increasing cancer cells' susceptibility through DNA damage and metabolic disruption.

Dutch startup Datamonk has raised €1.6 million in pre-seed funding to tackle the longstanding challenge of migrating and cleaning medical imaging data, a task critical to healthcare IT. By integrating agentic AI technology, Datamonk aims to streamline what remains a complex and labor-intensive process, facilitating faster and more efficient handling of large datasets.

Researchers have unveiled a potential breakthrough in stroke recovery therapies with DMT, a compound in plants and the human brain, showing promise in reducing brain damage by restoring the blood-brain barrier and minimizing inflammation.

Researchers are repurposing existing medications to combat metabolic dysfunction-associated steatotic liver disease, a prevalent condition affecting one in three adults globally. This approach, which utilizes existing drugs, appears to be both cost-effective and promising in mitigating one of the most common liver disorders worldwide.

Scientists have discovered a novel use for vinegar by enhancing its antibacterial capabilities with cobalt-based carbon nanoparticles, potentially providing a powerful tool against antibiotic-resistant bacteria. This advance could significantly impact global health by offering an alternative treatment for infections that resist traditional antibiotics.

Researchers from Massachusetts General Hospital have uncovered a potentially groundbreaking discovery linking a protein from immune cells, RELMy, to cardiac damage after heart attacks. The study highlights the protein's role in disrupting heart rhythm and suggests that blocking it could improve patient survival.

The Medical Travel Company, a healthcare startup based in the UK and India, has successfully raised €3.8 million. This investment is aimed at advancing their full-stack medical solution, which seeks to offer UK patients world-class treatment at affordable prices by leveraging international healthcare resources.